Cargando…

Management of cutaneous T cell lymphoma: new and emerging targets and treatment options

Cutaneous T cell lymphomas (CTCL) clinically and biologically represent a heterogeneous group of non-Hodgkin lymphomas, with mycosis fungoides and Sézary syndrome being the most common subtypes. Over the last decade, new immunological and molecular pathways have been identified that not only influen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Janet Y, Horwitz, Steven, Moskowitz, Alison, Myskowski, Patricia L, Pulitzer, Melissa, Querfeld, Christiane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308634/ https://www.ncbi.nlm.nih.gov/pubmed/22457602 http://dx.doi.org/10.2147/CMAR.S9660

Ejemplares similares

Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features
por: Argyropoulos, Kimon V., et al.
Publicado: (2020)

Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab
por: Virmani, Pooja, et al.
Publicado: (2017)

Solitary orange papule on the back of a middle-aged man
por: Geller, Shamir, et al.
Publicado: (2018)

Dermoscopic assessment of vascular structures in solitary small pink lesions—differentiating between good and evil
por: Geller, Shamir, et al.
Publicado: (2017)

Management of advanced cutaneous T-cell lymphoma: role of the dermatologist in the multidisciplinary team
por: Poligone, B, et al.
Publicado: (2015)

Relief of intractable pruritus with romidepsin in patients with cutaneous T‐cell lymphoma: A series of four cases
por: Poligone, Brian, et al.
Publicado: (2019)

Primary Cutaneous Multifocal Indolent CD8+ T-Cell Lymphoma: A Novel Primary Cutaneous CD8+ T-Cell Lymphoma
por: Petrogiannis-Haliotis, Tina, et al.
Publicado: (2023)

Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings
por: Wehkamp, Ulrike, et al.
Publicado: (2022)

A Rare Case of Cutaneous Plasmacytosis in a Korean Male
por: Georgesen, Corey, et al.
Publicado: (2017)

Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trial
por: Horwitz, Steven, et al.
Publicado: (2021)

Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash
por: Trum, Nicholas A., et al.
Publicado: (2021)

Publisher Correction to: Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings
por: Wehkamp, Ulrike, et al.
Publicado: (2023)

Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas
por: Fujimura, Taku, et al.
Publicado: (2021)

An update on the management of peripheral T-cell lymphoma and emerging treatment options
por: Phillips, Adrienne A, et al.
Publicado: (2011)

Primary Cutaneous Aggressive Epidermotropic Cytotoxic T-cell Lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas
por: Guitart, Joan, et al.
Publicado: (2017)

Multi-Kinase Inhibitor with Anti-p38γ Activity in Cutaneous T-Cell Lymphoma
por: Zhang, Xu Hannah, et al.
Publicado: (2018)

A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)—A Retrospective Cohort Study
por: Querfeld, Christiane, et al.
Publicado: (2021)

Emerging treatment options for the management of Hodgkin’s lymphoma: clinical utility of nivolumab
por: Bond, David A, et al.
Publicado: (2017)

The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma
por: Kim, Ellen J., et al.
Publicado: (2021)

New Targeted Treatments for Cutaneous T-cell Lymphomas
por: Bagot, Martine
Publicado: (2017)

Reprogramming of PD-1(+) M2-like tumor-associated macrophages with anti–PD-L1 and lenalidomide in cutaneous T cell lymphoma
por: Han, Zhen, et al.
Publicado: (2023)

Clinical Guidelines and New Molecular Targets for Cutaneous Lymphomas
por: Sugaya, Makoto
Publicado: (2021)

Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study
por: Querfeld, Christiane, et al.
Publicado: (2022)

Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders
por: Abdulla, Farah R., et al.
Publicado: (2021)

Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options
por: Vodicka, Prokop, et al.
Publicado: (2022)

Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma
por: Ollila, Thomas A, et al.
Publicado: (2019)

Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphoma
por: Yabe, Mariko, et al.
Publicado: (2020)

Romidepsin: evidence for its potential use to manage previously treated cutaneous T cell lymphoma
por: Poligone, Brian, et al.
Publicado: (2011)

Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell Lymphoma
por: Stuver, Robert, et al.
Publicado: (2023)

Emerging options for the management of scorpion stings
por: Chippaux, Jean-Philippe
Publicado: (2012)

Emerging Therapeutic Options for the Management of COPD
por: Reid, Debra J., et al.
Publicado: (2013)

Emerging treatment options for cryptosporidiosis
por: Love, Melissa S., et al.
Publicado: (2021)

CCR8 is a new therapeutic target in cutaneous T-cell lymphomas
por: Giustiniani, Jérôme, et al.
Publicado: (2022)

Current and emerging treatment options in primary mediastinal B-cell lymphoma
por: Fakhri, Bita, et al.
Publicado: (2021)

Treatment Options in Gastrointestinal Cutaneous Fistulas
por: Ashkenazi, Itamar, et al.
Publicado: (2017)

Histopathological Markers for Target Therapies in Primary Cutaneous Lymphomas
por: Sonego, Benedetta, et al.
Publicado: (2023)

Cutaneous leishmaniasis mimicking cutaneous lymphoma
por: Pires, Carla Andréa Avelar, et al.
Publicado: (2019)

Impact of COVID-19 pandemic on the management of cutaneous lymphomas
por: Mateeva, Valeria, et al.
Publicado: (2021)

Recent advances in understanding and managing cutaneous T-cell lymphomas
por: Brunner, Patrick M., et al.
Publicado: (2020)

Review of Treatment Options for the Management of Advanced Stage Hodgkin Lymphoma
por: Vellemans, Hélène, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e9cemeh31jc2enqhhga4ggqlu9